seAFOod logo
The seAFOod Trial
Leeds University
Leeds Insitute of Molecular Medicine

Systematic Evaluation of Aspirin and Fish Oil Bowel Polyp Prevention Trial

Frequently Asked Questions

Please see the patient information leaflets on the 'Useful Documents' page for detailed information on the study.

How can I join the study?
Unfortunately recruitment has now closed which means you can no longer join the study.

Who is funding and managing the trial?
The trial is led by Professor Mark Hull from St James’s University Hospital, Leeds and the University of Leeds, together with a team of doctors and researchers from the Bowel Cancer Screening Programme (BCSP) and the University of Bradford. The trial team also includes a Patient Representative with personal experience of the BCSP. The Clinical Trials Unit of the University of Nottingham is managing the trial along with the trial team. The work is being financed by a research grant awarded by the Efficacy and Mechanism Evaluation (EME) programme, which is funded by the Medical Research Council (MRC) and managed by the National Institute for Health Research (NIHR), which is part of the NHS.

Will my part in this trial be kept confidential?
If you consented to take part in this trial, the records obtained while you were in this trial as well as related health records will remain strictly confidential at all times. The information will be held securely on paper and electronically at your treating hospital under the provisions of the 1998 Data Protection Act. Your name will not be passed to anyone else outside the research team or the Sponsor, who is not involved in the trial. You were allocated a trial number, which was used as a code to identify you in all trial paperwork and samples.

Your records will be available to people authorised to work on the trial but may also need to be made available to people authorised by the Research Sponsor (University of Leeds), which is the organisation responsible for ensuring that the trial is carried out correctly. By signing the consent form, you agree to this and for any further research that may be conducted in relation to it, even if you withdraw from the trial.

The information collected about you may also be shown to authorised people from the UK Regulatory Authority and Independent Ethics Committee; this is to ensure that the trial is carried out to the highest possible scientific standards. All will have a duty of confidentiality to you as a research participant.

In line with Good Clinical Practice guidelines, at the end of the trial, your data will be securely archived for a minimum of 15 years. Arrangements for confidential destruction will then be made.

Who can I speak to, to find out more about the study?
Please speak with your Specialist Screening Practitioner or the trial manager, Sarah Fahy, on 0115 823 1607 or e-mail

You can also find further information on the Cancer Research UK website.